Market open
Alumis Inc./$ALMS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Alumis Inc.
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.
Ticker
$ALMS
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
169
Website
Alumis Inc. Metrics
BasicAdvanced
$208M
-
-$10.38
-
-
Price and volume
Market cap
$208M
52-week high
$10.49
52-week low
$3.18
Average daily volume
1.2M
Financial strength
Current ratio
6.014
Quick ratio
5.662
Long term debt to equity
11.213
Total debt to equity
11.811
Management effectiveness
Return on assets (TTM)
-87.31%
Return on equity (TTM)
-198.66%
Valuation
Price to book
0.8
Price to tangible book (TTM)
0.8
Price to free cash flow (TTM)
-0.423
Growth
Earnings per share change (TTM)
-85.60%
Alumis Inc. News
AllArticlesVideos
Alumis and ACELYRIN Announce Amended Merger Agreement
GlobeNewsWire·2 weeks ago
ACELYRIN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acelyrin, Inc. - SLRN
Business Wire·2 weeks ago
3 Biopharmaceutical Stocks Bucking the Sell-Off
MarketBeat·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Alumis Inc. stock?
Alumis Inc. (ALMS) has a market cap of $208M as of May 02, 2025.
What is the P/E ratio for Alumis Inc. stock?
The price to earnings (P/E) ratio for Alumis Inc. (ALMS) stock is 0 as of May 02, 2025.
Does Alumis Inc. stock pay dividends?
No, Alumis Inc. (ALMS) stock does not pay dividends to its shareholders as of May 02, 2025.
When is the next Alumis Inc. dividend payment date?
Alumis Inc. (ALMS) stock does not pay dividends to its shareholders.
What is the beta indicator for Alumis Inc.?
Alumis Inc. (ALMS) does not currently have a Beta indicator.